CASTLEARK MANAGEMENT LLC

Position in VCYT — Veracyte, Inc.

CIK 1106832 CHICAGO, IL

Position in VCYT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,229,499

-$1,552,547 QoQ

Shares Held

72,016

-63.1% QoQ

Ownership

0.090%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#92

of 365 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CASTLEARK MANAGEMENT LLC holds $31,877,319 across 5 Diagnostics & Research names. VCYT ranks #4 (13.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GH	Guardant Health, Inc.	80,293	$12,046,358
2	CRL	Charles River Laboratories International, Inc.	36,045	$8,174,645
3	DGX	Quest Diagnostics Inc	31,480	$6,672,186
4	VCYT	Veracyte, Inc. This page	72,016	$4,229,499
5	NTRA	Natera, Inc.	2,780	$754,631

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,229,499	72,016	-63.1%	Shares	Sole	2026-08-14
2025-03-31	$5,782,046	195,010	+15.1%	Shares	Sole	2025-05-15
2024-12-31	$6,709,428	169,430	-4.0%	Shares	Sole	2025-02-18
2024-09-30	$6,010,102	176,560	-0.9%	Shares	Sole	2024-11-15
2023-12-31	$4,902,557	178,210	+40.2%	Shares	Sole	2024-02-15
2023-09-30	$2,837,919	127,090	-1.1%	Shares	Sole	2023-11-15
2023-06-30	$3,271,876	128,460	+15.8%	Shares	Sole	2023-08-16
2023-03-31	$2,473,070	110,900	+260.4%	Shares	Sole	2023-05-16
2022-12-31	$730,172	30,770	-67.0%	Shares	Sole	2023-02-10
2021-09-30	$4,331,462	93,250	-55.2%	Shares	Sole	2021-11-12
2021-03-31	$11,193,813	208,257	-17.3%	Shares	Sole	2021-05-14
2020-12-31	$12,324,658	251,832	—	Shares	Sole	2021-02-17
No filing history on record for this holder in this stock.